AAMU
WST icon

Amundi Asset Management US’s West Pharmaceutical WST Stock Holding History

Amundi Asset Management US’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$75.1M Buy
266,377
+26,715
+11% +$7.65M 0.06% 328
2020
Q4 		$67.9M Buy
239,662
+463
+0.2% +$130K 0.06% 324
2020
Q3 		$65.8M Buy
239,199
+28,408
+13% +$7.52M 0.07% 279
2020
Q2 		$47.9M Buy
210,791
+54,596
+35% +$10.7M 0.06% 316
2020
Q1 		$23.8M Buy
156,195
+14,771
+10% +$2.27M 0.04% 368
2019
Q4 		$21.3M Sell
141,424
-10,618
-7% -$1.55M 0.02% 540
2019
Q3 		$21.6M Buy
152,042
+4,706
+3% +$648K 0.03% 488
2019
Q2 		$41.1M Buy
147,336
+115,162
+358% +$13.6M 0.03% 374
2019
Q1 		$3.54M Sell
32,174
-24,944
-44% -$2.59M 0.01% 982
2018
Q4 		$5.6K Sell
57,118
-4,936
-8% -$536K 0.01% 809
2018
Q3 		$7.66M Buy
62,054
+53,365
+614% +$5.98M 0.01% 802
2018
Q2 		$863K Sell
8,689
-33,575
-79% -$3.09M ﹤0.01% 1276
2018
Q1 		$3.73M Buy
42,264
+1,125
+3% +$105K 0.01% 926
2017
Q4 		$4.06M Buy
+41,139
New +$4.03M 0.01% 897

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Asset Management US's WST Position: Q1 2021 in Review

Amundi Asset Management US increased its West Pharmaceutical (WST) stake by 11% in Q1 2021, buying an estimated $7.65M and bringing the position to 266,377 shares worth $75.1M. The position accounts for 0.06% of the portfolio, ranked #328.

Amundi Asset Management US first reported a position in WST in Q4 2017 and has held it in 14 quarters since. 591 funds tracked by Wall St. Rank hold WST as of Q1 2021.

  • Amundi Asset Management US held 266,377 shares of West Pharmaceutical worth $75.1M as of Q1 2021.
  • Amundi Asset Management US bought 26,715 West Pharmaceutical shares in Q1 2021, an estimated $7.65M.
  • West Pharmaceutical made up 0.06% of Amundi Asset Management US's portfolio in Q1 2021, its #328 holding.
  • Amundi Asset Management US first reported a position in West Pharmaceutical in Q4 2017 and has held it in 14 quarters since.
  • 591 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.